Cargando…

Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis

INTRODUCTION: Betamethasone dipropionate (BD) has anti-inflammatory, immunomodulatory, and antiproliferative activity. The aim of the current work was to test the hypothesis that the addition of corticosteroid such as BD and a keratolytic agent such as salicylic acid in nanocarrier based microemulsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baboota, Sanjula, Alam, Md Sarfaraz, Sharma, Shrestha, Sahni, Jasjeet K, Kumar, Anil, Ali, Javed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465136/
https://www.ncbi.nlm.nih.gov/pubmed/23071936
http://dx.doi.org/10.4103/2230-973X.85963
_version_ 1782245512740601856
author Baboota, Sanjula
Alam, Md Sarfaraz
Sharma, Shrestha
Sahni, Jasjeet K
Kumar, Anil
Ali, Javed
author_facet Baboota, Sanjula
Alam, Md Sarfaraz
Sharma, Shrestha
Sahni, Jasjeet K
Kumar, Anil
Ali, Javed
author_sort Baboota, Sanjula
collection PubMed
description INTRODUCTION: Betamethasone dipropionate (BD) has anti-inflammatory, immunomodulatory, and antiproliferative activity. The aim of the current work was to test the hypothesis that the addition of corticosteroid such as BD and a keratolytic agent such as salicylic acid in nanocarrier based microemulsions formulation would result in enhancement and sustaining of corticosteroid delivery rate leading to better anti-psoriatic activity. Clinical use of BD is restricted to some extent due to its poor permeability across the skin. So to increase its permeation across the skin, microemulsion-based gel formulations were prepared and characterised. MATERIALS AND METHODS: Microemulsions were prepared by aqueous phase titration method, using oleic acid:sefsol (1.5:1), Tween 20, isopropyl alcohol, and distilled water as the oil phase, surfactant, cosurfactant and aqueous phase, respectively. Selected formulations were subjected to physical stability studies and consequently in vitro skin permeation studies. Surface studies of optimized formulation were done by transmission electron microscopy. In vivo anti-inflammatory activity was done by carageenan-induced raw paw edema method. RESULTS: The droplet size of microemulsions ranged from 60 to 190 nm. The optimized formulation exhibited viscosity 28.55 ± 2.03 mP, refractive index 1.409, pH 6.4, and conductivity 10(-4) scm(-1). The optimized microemulsion was converted into hydrogel using carbopol 934, and salicylic acid was incorporated into it. Drug deposition in skin was found to be 29.73 μg/mg. Assessment of skin permeation was done by histopathology studies which indicated changes in the structure of epidermal membrane of skin. In vivo anti-inflammatory activity indicated 72.11% and 43.96% inhibition of inflammation in case of developed microemulsion gel and marketed gel, respectively. CONCLUSIONS: The developed microemulsion gel containing BD and salicylic acid provided sustained and good anti-inflammatory activity for the treatment of psoriasis.
format Online
Article
Text
id pubmed-3465136
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34651362012-10-15 Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis Baboota, Sanjula Alam, Md Sarfaraz Sharma, Shrestha Sahni, Jasjeet K Kumar, Anil Ali, Javed Int J Pharm Investig Original Research Article INTRODUCTION: Betamethasone dipropionate (BD) has anti-inflammatory, immunomodulatory, and antiproliferative activity. The aim of the current work was to test the hypothesis that the addition of corticosteroid such as BD and a keratolytic agent such as salicylic acid in nanocarrier based microemulsions formulation would result in enhancement and sustaining of corticosteroid delivery rate leading to better anti-psoriatic activity. Clinical use of BD is restricted to some extent due to its poor permeability across the skin. So to increase its permeation across the skin, microemulsion-based gel formulations were prepared and characterised. MATERIALS AND METHODS: Microemulsions were prepared by aqueous phase titration method, using oleic acid:sefsol (1.5:1), Tween 20, isopropyl alcohol, and distilled water as the oil phase, surfactant, cosurfactant and aqueous phase, respectively. Selected formulations were subjected to physical stability studies and consequently in vitro skin permeation studies. Surface studies of optimized formulation were done by transmission electron microscopy. In vivo anti-inflammatory activity was done by carageenan-induced raw paw edema method. RESULTS: The droplet size of microemulsions ranged from 60 to 190 nm. The optimized formulation exhibited viscosity 28.55 ± 2.03 mP, refractive index 1.409, pH 6.4, and conductivity 10(-4) scm(-1). The optimized microemulsion was converted into hydrogel using carbopol 934, and salicylic acid was incorporated into it. Drug deposition in skin was found to be 29.73 μg/mg. Assessment of skin permeation was done by histopathology studies which indicated changes in the structure of epidermal membrane of skin. In vivo anti-inflammatory activity indicated 72.11% and 43.96% inhibition of inflammation in case of developed microemulsion gel and marketed gel, respectively. CONCLUSIONS: The developed microemulsion gel containing BD and salicylic acid provided sustained and good anti-inflammatory activity for the treatment of psoriasis. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3465136/ /pubmed/23071936 http://dx.doi.org/10.4103/2230-973X.85963 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Baboota, Sanjula
Alam, Md Sarfaraz
Sharma, Shrestha
Sahni, Jasjeet K
Kumar, Anil
Ali, Javed
Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis
title Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis
title_full Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis
title_fullStr Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis
title_full_unstemmed Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis
title_short Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis
title_sort nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465136/
https://www.ncbi.nlm.nih.gov/pubmed/23071936
http://dx.doi.org/10.4103/2230-973X.85963
work_keys_str_mv AT babootasanjula nanocarrierbasedhydrogelofbetamethasonedipropionateandsalicylicacidfortreatmentofpsoriasis
AT alammdsarfaraz nanocarrierbasedhydrogelofbetamethasonedipropionateandsalicylicacidfortreatmentofpsoriasis
AT sharmashrestha nanocarrierbasedhydrogelofbetamethasonedipropionateandsalicylicacidfortreatmentofpsoriasis
AT sahnijasjeetk nanocarrierbasedhydrogelofbetamethasonedipropionateandsalicylicacidfortreatmentofpsoriasis
AT kumaranil nanocarrierbasedhydrogelofbetamethasonedipropionateandsalicylicacidfortreatmentofpsoriasis
AT alijaved nanocarrierbasedhydrogelofbetamethasonedipropionateandsalicylicacidfortreatmentofpsoriasis